NMS·Healthcare·$192M·#191 / 520 in Healthcare
LFCR Lifecore Biomedical, Inc.
54SPECULATIVE
CATEGORY BREAKDOWN
GROWTH1
QUALITY30
STABILITY100
VALUATION98
GOVERNANCE43
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+0.5%
1
> 50% strong
Gross Margin
Revenue retained after direct costs
31.3%
42
> 50% strong
Cash Runway
Months of cash at current burn rate
1018 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
-1004.1%
100
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.5x
98
< 3x strong
Rule of 40
Growth rate plus operating margin
-9
13
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
2.4%
19
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+1.3%
92
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE LFCR WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when LFCR's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.